2019

1. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

   Therapeutic Advances in Gastroenterology, Vol. 12

2. Increased risk of thiopurine-related adverse events in elderly patients with IBD

   Alimentary Pharmacology and Therapeutics, Vol. 50, Núm. 7, pp. 780-788